Phase IIa study of αDC1 vaccines targeting HER2/HER3 combined with pembrolizumab in patients with asymptomatic brain metastasis from breast cancer. This is an ASCO Meeting Abstract from the 2025 ASCO ...

Immunological correlates from phase I study of CARv3-TEAM-E in patients with recurrent glioblastoma (GBM): INCIPIENT trial.

In this exclusive interview, we spoke with the team at ChucaoTech, a Chilean technology company specializing in innovative nanobubble injection systems. ChucaoTech is revolutionizing the mining ...